Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Color Vision Defects

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Color Vision Defects in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Color Vision Defects: Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hulka, LM1
Wagner, M1
Preller, KH1
Jenni, D1
Quednow, BB1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Color Vision Defects

ArticleYear
Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine-Related

2013